ARCHIVES

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: PHS Established Two Scientific Integrity Offices; Workshop On Ethical Issues Planned

August 18, 1989

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989

Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020

January 28, 2011

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

In the Cancer Centers: Margaret Kripke of M.D. Anderson to Retire in 2007.

June 16, 2006